Doing some research...
Total assets reported in FY2025.
Total liabilities reported in FY2025.
Shareholders' equity reported in FY2025.
Equity as a share of the latest capital base.
Review the reported balance sheet and jump directly to the source filing for any fiscal year.
Centene Corporation’s balance sheet over the past five years shows a generally large, but somewhat volatile, asset base. Total assets were broadly stable in the $76.9 billion–$84.6 billion range, peaking in 2023 at $84.6 billion before easing to $82.4 billion in 2024 and $76.7 billion in 2025. This suggests the company has maintained a substantial operating scale, but the recent decline in assets may reflect working-capital movements, investment changes, or balance-sheet optimization rather than a long-term contraction in the business. Liabilities remained elevated throughout the period, moving from $51.4 billion in 2021 to $58.7 billion in 2023, then declining modestly to $55.9 billion in 2024 and $56.7 billion in 2025. Stockholders’ equity has been more variable: it fell from $26.9 billion in 2021 to $24.2 billion in 2022, recovered to $25.9 billion in 2023, jumped to $26.4 billion in 2024, and then declined sharply to $20.0 billion in 2025. Overall, Centene remains well capitalized, but the 2025 drop in equity alongside lower assets indicates some weakening in net balance-sheet strength. In industry context, managed care and health insurance companies like Centene often carry large liability balances because of medical claims reserves and other short-duration obligations, so a leveraged-looking balance sheet is not unusual. Still, the recent reduction in equity deserves attention, as it may signal pressure from profitability, reserve development, or other non-operating items. The company’s financial position remains sizable and operationally important, but the latest year suggests a less robust cushion than in prior periods.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.